ROLE OF CYTOCHROME P4502E1 IN ALCOHOLIC LIVER-DISEASE PATHOGENESIS

被引:134
|
作者
MORIMOTO, M
HAGBJORK, AL
NANJI, AA
INGELMANSUNDBERG, M
LINDROS, KO
FU, PC
ALBANO, E
FRENCH, SW
机构
[1] UCLA,HARBOR MED CTR,DEPT PATHOL,TORRANCE,CA 90509
[2] KAROLINSKA INST,DEPT PHYSIOL CHEM,S-10401 STOCKHOLM,SWEDEN
[3] NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
[4] HARVARD UNIV,SCH MED,BOSTON,MA
[5] STATE ALCOHOL MONOPOLY,RES LABS,HELSINKI,FINLAND
[6] UNIV TORINO,DEPT EXPTL MED & ONCOL,TURIN,ITALY
关键词
ALD MODEL; LIPID PEROXIDATION; PUFA; FATTY ACID; LINOLEIC ACID; PROTEIN ADDUCTS; DIALLYL SULFIDE; CYTOCHROME P4502E1;
D O I
10.1016/0741-8329(93)90065-V
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The intragastric tube feeding model is ideal for the study of the role of dietary factors and the effect of drugs on experimental alcoholic liver disease (ALD), since the model allows us to study the effect of a single variable in the diet on the pathology of liver where the blood alcohol level (BAL) is maintained over 150 mg%. By varying the dietary fatty acid composition we showed that the pathology was worsened by increasing linoleic acid or polyunsaturated fatty acids (PUFAs) in the diet where cytochrome P4502E1 (CYP2E1) was increased posttranslationally by high BAL. Concomitant with the increase in CYP2E1 there was evidence for an increase in lipid peroxidation (LP) by microsomes. Protein adducts of the products of LP were increased in the blood. Isoniazid (INH) enhanced this process and the pathology of ALD when INH was fed at therapeutic levels with ethanol. Preliminary studies show that diallyl sulfide, which inhibits and destroys liver CYP2E1 selectively, also modified the pathologic effects of ethanol. Thus we postulate that CYP2E1 induction plays a central role in the pathogenesis of ALD.
引用
收藏
页码:459 / 464
页数:6
相关论文
共 50 条
  • [31] CHANGES IN MICROSOMAL PHOSPHOLIPASES AND ARACHIDONIC-ACID IN EXPERIMENTAL ALCOHOLIC LIVER-INJURY - RELATIONSHIP TO CYTOCHROME-P-450 2E1 INDUCTION AND CONJUGATED DIENE FORMATION
    NANJI, AA
    ZHAO, SP
    LAMB, RG
    SADRZADEH, SMH
    DANNENBERG, AJ
    WAXMAN, DJ
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1993, 17 (03) : 598 - 603
  • [32] Impact of vitamin E on redox biomarkers in non-alcoholic fatty liver disease
    Podszun, Maren C.
    Frank, Jan
    REDOX BIOLOGY, 2021, 42
  • [33] Modulation of CYP4502E1 and oxidative stress by testosterone in liver and kidney of benzene treated rats
    Verma, Yeshvandra
    Rana, S. V. S.
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2008, 46 (08) : 568 - 572
  • [34] Alcohol and Cancer: An Overview with Special Emphasis on the Role of Acetaldehyde and Cytochrome P450 2E1
    Seitz, Helmut K.
    Mueller, Sebastian
    BIOLOGICAL BASIS OF ALCOHOL-INDUCED CANCER, 2015, 815 : 59 - 70
  • [35] Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease
    Koroglu, Emine
    Canbakan, Billur
    Atay, Kadri
    Hatemi, Ibrahim
    Tuncer, Murat
    Dobrucali, Ahmet
    Sonsuz, Abdullah
    Gultepe, Ilhami
    Senturk, Hakan
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2016, 27 (04): : 361 - 366
  • [36] The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Maciejewska-Markiewicz, Dominika
    Stachowska, Ewa
    Hawrylkowicz, Viktoria
    Stachowska, Laura
    Prowans, Piotr
    BIOMOLECULES, 2021, 11 (07)
  • [37] Acetaminophen induced acute liver failure via oxidative stress and JNK activation: Protective role of taurine by the suppression of cytochrome P450 2E1
    Das, Joydeep
    Ghosh, Jyotirmoy
    Manna, Prasenjit
    Sil, Parames C.
    FREE RADICAL RESEARCH, 2010, 44 (03) : 340 - 355
  • [38] Role of the Liver Capsule as a Traditional Medicine Formulation in the Treatment of Non-Alcoholic Fatty Liver Disease in Rats
    Albooyeh, Sogol
    Khadem, Ebrahim
    Jeivad, Fereshteh
    Vaghefi, Atefeh Monir
    Hassanzadeh, Gholamreza
    Aliasl, Fatemeh
    Gholami, Maryam
    Delasoud, Shabnam
    Sabzevari, Omid
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2024, 57 (10) : 1539 - 1545
  • [39] Role of the Liver Capsule as a Traditional Medicine Formulation in the Treatment of Non-Alcoholic Fatty Liver Disease in Rats
    Sogol Albooyeh
    Ebrahim Khadem
    Fereshteh Jeivad
    Atefeh Monir Vaghefi
    Gholamreza Hassanzadeh
    Fatemeh Aliasl
    Maryam Gholami
    Shabnam Delasoud
    Omid Sabzevari
    Pharmaceutical Chemistry Journal, 2024, 57 : 1539 - 1545
  • [40] OXIDATIVE AND REDUCTIVE METABOLISM BY CYTOCHROME-P450-2E1
    KOOP, DR
    FASEB JOURNAL, 1992, 6 (02): : 724 - 730